CDC withdraws fraudulent PCR testing protocol that was used to falsify covid “positives”

CDC withdraws fraudulent PCR testing protocol that was used to falsify covid “positives” to push the pandemic

After December 31, 2021, CDC will withdraw the request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of the CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel, the assay first introduced in February 2020 for detection of SARS-CoV-2 only. CDC is providing this advance notice for clinical laboratories to have adequate time to select and implement one of the many FDA-authorized alternatives

Click here to read